QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apyx-medical-submits-fda-510k-for-device-label-expansion-of-ayon-body-contouring-system

Initiated Nationwide Commercial Launch of AYON in SeptemberThe Company is Hosting a Virtual Key Opinion Leader Event to Discuss...

 apyx-medical-launches-renuvion-in-china

Strong clinical interest and early procedures completedEntered into distribution agreement with GlamMoon, a division of BeauCar...

 apyx-medical-affirms-fy2025-sales-guidance-of-4760m-4900m-vs-4803m-est

Apyx Medical (NASDAQ:APYX) affirms FY2025 sales outlook from $47.60 million-$49.00 million to $47.60 million-$49.00 million vs ...

 apyx-medical-q1-eps-010-beats-012-estimate-sales-943m-beat-939m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) ...

 apyx-medical-revises-2025-total-revenue-outlook-from-476m---495m-to-476m---490m-est-48462m

The Company continues to expect operating expenses of less than $40.0 million for the year ended December 31, 2025.

 apyx-medical-q4-2024-gaap-eps-012-beats-015-estimate-sales-1422m-beat-1339m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) ...

 apyx-medical-announces-q4-2024-revenue-between-141m-143m-a-3-4-decrease-yoy-advanced-energy-revenue-flat-at-120m-122m-oem-revenue-down-17-to-21m-fy24-revenue-between-480m-482m-an-8-decrease-yoy-advanced-energy-down-11-to-385m-387m-oem-up-6-to-95m

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofreque...

 apyx-medical-corp-submits-510k-premarket-notification-to-the-us-fda-fortthe-ayon-body-contouring-system

Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary heli...

 apyx-medical-expects-2025-revenues-of--476m-495m-compared-to-consensus-of-54045m

The Company is introducing revenue guidance for the year ending December 31, 2025:Total revenue in the range of $47.6 million t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION